(CRSP) Crispr Therapeutics complete technical analysis [charts+indicators] | Buy/Sell Crispr Therapeutics | (CRSP) share price targets
Complete technical analysis of Crispr Therapeutics (CRSP) by charts plus indicators, forecast predictions and share price targets for Crispr Therapeutics (CRSP)
Crispr Therapeutics trades in USA in Health Care sector.
Showing technical analysis as on 2024-07-09 View latest technical analysis
10 day averaged volume of Crispr Therapeutics is 1031240
Date | Daily Closing Price | Open | High | Low | Volume |
09 Tue Jul 2024 | 55.03 | 53.25 | 55.15 | 52.83 | 0.877 times |
08 Mon Jul 2024 | 53.23 | 53.66 | 54.83 | 53.17 | 1.02 times |
05 Fri Jul 2024 | 53.10 | 53.69 | 53.69 | 52.31 | 1.046 times |
03 Wed Jul 2024 | 53.90 | 53.60 | 54.74 | 53.14 | 0.659 times |
03 Wed Jul 2024 | 53.90 | 53.60 | 54.74 | 53.14 | 0.659 times |
02 Tue Jul 2024 | 53.12 | 53.98 | 53.98 | 52.52 | 1.027 times |
01 Mon Jul 2024 | 53.95 | 54.02 | 55.67 | 53.31 | 1.254 times |
28 Fri Jun 2024 | 54.01 | 55.53 | 55.69 | 53.33 | 1.274 times |
27 Thu Jun 2024 | 55.38 | 56.66 | 57.98 | 55.31 | 1.199 times |
26 Wed Jun 2024 | 56.63 | 55.47 | 56.80 | 55.01 | 1.017 times |
My analysis of stock is bearish for shortterm, but stock is semi over sold and there are some chances of seeing a recovery tomorrow. Use 53.5 as stoploss in an intra day buy trade for a target of 57.43. However, stock will show a bearish move below 53.5.
Share price targets for Crispr Therapeutics (CRSP)
Target Type | Value |
Downside Target | 51.02 |
Downside Target | 52.31 |
Downside Target | 54.74 |
Upside Target | 55.67 |
Upside Target | 58.31 |
Upside Target | 59.18 |
Upside Target | 62.17 |
Upside Target | 67.52 |
Upside Target | 67.88 |
Upside Target | 68.39 |
Upside Target | 87.08 |
Intraday share price targets for Crispr Therapeutics (CRSP)
Target Type | Value |
Downside Intraday Target | 53.52 |
Downside Intraday Target | 52.02 |
Upside Intraday Target | 55.84 |
Upside Intraday Target | 56.66 |
Downside Intraday Target | 54.34 |
Weekly technical analysis of Crispr Therapeutics (CRSP)
Date | Weekly Closing Price | Open | High | Low | Volume |
09 Tue Jul 2024 | 55.03 | 53.66 | 55.15 | 52.83 | 1.113 times |
05 Fri Jul 2024 | 53.10 | 53.60 | 54.74 | 52.31 | 0.58 times |
03 Wed Jul 2024 | 53.90 | 54.02 | 55.67 | 52.52 | 0.544 times |
28 Fri Jun 2024 | 54.01 | 56.27 | 58.31 | 53.33 | 0.9 times |
21 Fri Jun 2024 | 56.24 | 62.03 | 62.17 | 55.08 | 2.891 times |
Price has moved up this week, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming weeks.
Monthly technical analysis of Crispr Therapeutics (CRSP)
Date | Monthly Closing Price | Open | High | Low | Volume |
09 Tue Jul 2024 | 55.03 | 54.02 | 55.67 | 52.31 | 0.237 times |
28 Fri Jun 2024 | 54.01 | 54.82 | 67.88 | 53.33 | 1.023 times |
31 Fri May 2024 | 53.74 | 53.16 | 59.18 | 51.02 | 0.974 times |
30 Tue Apr 2024 | 52.99 | 68.14 | 68.39 | 52.73 | 1.058 times |
Scroll below to view daily charts
Price has moved up this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Crispr Therapeutics (CRSP)
Price action analysis of Crispr Therapeutics ( (CRSP) ) based on a short term time period is positive, but buyers have become active on the stock recently. This cannot be a definite uptrend, specially if selected time duration is small.
Price action analysis of Crispr Therapeutics ( (CRSP) ) based on a short term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
Price action analysis of Crispr Therapeutics ( (CRSP) ) based on a short to mid term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Crispr Therapeutics ( (CRSP) ) based on a mid to longer term time period is neutral. A longer time frame might give a better analysis.
ADX buy sell signal for Crispr Therapeutics stock for short term is SELL. Signal strength is Strong and stock is gaining momentum.
MACD generated a SELL signal for Crispr Therapeutics in short term and the sell signal is strong.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Crispr Therapeutics Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are weakening, and bulls are picking up momentum!
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be moving up
CCI has generated a buy signal for Crispr Therapeutics in short term and BUY signal is strong.
RSI is generating a SELL signal in short term but selling is losing momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Crispr Therapeutics is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 54.24 and Crispr Therapeutics (CRSP) stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is falling down
People seem to be coming out and selling the Crispr Therapeutics (CRSP) stock. Volume based technical analysis of Crispr Therapeutics (CRSP) stock is negative.
Crispr Therapeutics Stock has given negative returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Crispr Therapeutics ( (CRSP) ) based on a short term time period is positive, but buyers have become active on the stock recently. This cannot be a definite uptrend, specially if selected time duration is small.
Price action analysis of Crispr Therapeutics ( (CRSP) ) based on a short term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
Price action analysis of Crispr Therapeutics ( (CRSP) ) based on a short to mid term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Crispr Therapeutics ( (CRSP) ) based on a mid to longer term time period is neutral. A longer time frame might give a better analysis.
ADX buy sell signal for Crispr Therapeutics stock for short term is SELL. Signal strength is Strong and stock is gaining momentum.
MACD generated a SELL signal for Crispr Therapeutics in short term and the sell signal is strong.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Crispr Therapeutics Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are weakening, and bulls are picking up momentum!
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be moving up
CCI has generated a buy signal for Crispr Therapeutics in short term and BUY signal is strong.
RSI is generating a SELL signal in short term but selling is losing momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Crispr Therapeutics is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 54.24 and Crispr Therapeutics (CRSP) stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is falling down
People seem to be coming out and selling the Crispr Therapeutics (CRSP) stock. Volume based technical analysis of Crispr Therapeutics (CRSP) stock is negative.
Crispr Therapeutics Stock has given negative returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.